Evidence map›Paper›PMID 26203800›Full record

ArticleAmerican journal of respiratory cell and molecular biology2016

Targeted Type 2 Alveolar Cell Depletion. A Dynamic Functional Model for Lung Injury Repair.

Orquidea Garcia, Michael J Hiatt, Amber Lundin, Jooeun Lee, Raghava Reddy, Sonia Navarro, Alex Kikuchi, Barbara Driscoll

Abstract read
In one paragraph

Article in American journal of respiratory cell and molecular biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 1 synthesis or guideline pooled it, 62 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Degradation of oxidized phospholipids by lysosomal phospholipase A2 regulates pulmonary fibrosis.American journal of physiology. Lung cellular and molecular physiology · 2025
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Deletion ofJournal of thoracic disease · 2023
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Orquidea Garcia1 Developmental Biology and Regenerative Medicine Program, Department of Surgery, Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, California; and.
Michael J Hiatt1 Developmental Biology and Regenerative Medicine Program, Department of Surgery, Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, California; and.
Amber Lundin2 California Institute for Regenerative Medicine (CIRM)-Bridges to Stem Cell Research Program, Pasadena City College, Pasadena, California.
Jooeun Lee1 Developmental Biology and Regenerative Medicine Program, Department of Surgery, Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, California; and.
Raghava Reddy1 Developmental Biology and Regenerative Medicine Program, Department of Surgery, Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, California; and.
Sonia Navarro1 Developmental Biology and Regenerative Medicine Program, Department of Surgery, Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, California; and.
Alex Kikuchi1 Developmental Biology and Regenerative Medicine Program, Department of Surgery, Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, California; and.
Barbara Driscoll1 Developmental Biology and Regenerative Medicine Program, Department of Surgery, Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, California; and.
Children's Hospital of Los Angeles · USPasadena City College · US

Funding

Aveolar Epithelial Cells: Development and RepairR01HL065352 · NHLBI · CHILDREN'S HOSPITAL OF LOS ANGELES · PI DRISCOLL, BARBARA · 2000 to 2013
$4.2M
NHLBI NIH HHS R01 HL 65,352
6 · The paper itself

Abstract

Type 2 alveolar epithelial cells (AEC2) are regarded as the progenitor population of the alveolus responsible for injury repair and homeostatic maintenance. Depletion of this population is hypothesized to underlie various lung pathologies. Current models of lung injury rely on either uncontrolled, nonspecific destruction of alveolar epithelia or on targeted, nontitratable levels of fixed AEC2 ablation. We hypothesized that discrete levels of AEC2 ablation would trigger stereotypical and informative patterns of repair. To this end, we created a transgenic mouse model in which the surfactant protein-C promoter drives expression of a mutant SR39TK herpes simplex virus-1 thymidine kinase specifically in AEC2. Because of the sensitivity of SR39TK, low doses of ganciclovir can be administered to these animals to induce dose-dependent AEC2 depletion ranging from mild (50%) to lethal (82%) levels. We demonstrate that specific levels of AEC2 depletion cause altered expression patterns of apoptosis and repair proteins in surviving AEC2 as well as distinct changes in distal lung morphology, pulmonary function, collagen deposition, and expression of remodeling proteins in whole lung that persist for up to 60 days. We believe SPCTK mice demonstrate the utility of cell-specific expression of the SR39TK transgene for exerting fine control of target cell depletion. Our data demonstrate, for the first time, that specific levels of type 2 alveolar epithelial cell depletion produce characteristic injury repair outcomes. Most importantly, use of these mice will contribute to a better understanding of the role of AEC2 in the initiation of, and response to, lung injury.

Indexed as

RegenerationAlveolar Epithelial CellsAnimalsApoptosisCell ProliferationCells, CulturedCell ShapeCollagenDisease Models, AnimalDose-Response Relationship, DrugGanciclovirGene Expression Regulation, EnzymologicGenetic Predisposition to DiseaseHumansHyperoxiaLung InjuryCollagenGanciclovirPulmonary Surfactant-Associated Protein CSFTPC protein, humanThymidine KinaseViral Proteinsdistal lung injuryinjury-repairlung diseasetype 2 alveolar epithelial cells (AEC2)

Identifiers

PMID26203800
PMCPMC4821031
OpenAlexW1831343124

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.